product summary
Loading...
company name :
MyBioSource
product type :
protein
product name :
Collagen, type VII Immunizing Peptide
catalog :
MBS426106
quantity :
0.1 mg
price :
190 USD
more info or order :
product information
catalog number :
MBS426106
products type :
Peptide
products full name :
Collagen, type VII Immunizing Peptide
products short name :
Collagen, type VII
products name syn :
Collagen, type VII; collagen, type VII, alpha 1 (epidermolysis bullosa, dystrophic, dominant and recessive); COL7A1; HGNC: 2214; EBD1; EBDCT; EBR1; LC collagen; alpha 1 type VII collagen; collagen VII; alpha-1 polypeptide; long chain collagen; collagen, ty; Collagen, type VII; Collagen, type VII
other names :
collagen alpha-1(VII) chain; Collagen alpha-1(VII) chain; collagen alpha-1(VII) chain; collagen type VII alpha 1; Long-chain collagen; LC collagen
products gene name :
COL7A1
other gene names :
COL7A1; COL7A1; EBD1; EBR1; EBDCT; NDNC8; LC collagen
uniprot entry name :
CO7A1_HUMAN
reactivity :
Human, Mouse, Rat, Dog, Pig
sequence length :
2944
sequence :
C-TVQYSDDPRTEF
form :
100ug of dried peptide
storage stability :
Shipped at ambient temperature, store at -20 degree C
ncbi gi num :
4502961
ncbi acc num :
NP_000085.1
ncbi gb acc num :
NM_000094.3
ncbi mol weight :
292,267 Da
ncbi pathways :
Anchoring Fibril Formation Pathway (1270248); Asparagine N-linked Glycosylation Pathway (1268714); Assembly Of Collagen Fibrils And Other Multimeric Structures Pathway (1270247); COPII (Coat Protein 2) Mediated Vesicle Transport Pathway (1268727); Cargo Concentration In The ER Pathway (1309087); Collagen Biosynthesis And Modifying Enzymes Pathway (1270246); Collagen Formation Pathway (1270245); ER To Golgi Anterograde Transport Pathway (1268726); Extracellular Matrix Organization Pathway (1270244); Membrane Trafficking Pathway (1269877)
ncbi summary :
This gene encodes the alpha chain of type VII collagen. The type VII collagen fibril, composed of three identical alpha collagen chains, is restricted to the basement zone beneath stratified squamous epithelia. It functions as an anchoring fibril between the external epithelia and the underlying stroma. Mutations in this gene are associated with all forms of dystrophic epidermolysis bullosa. In the absence of mutations, however, an acquired form of this disease can result from an autoimmune response made to type VII collagen. [provided by RefSeq, Jul 2008]
uniprot summary :
COL7A1: the alpha chain of type VII collagen, an extra-cellular basement membrane protein restricted to the zone beneath stratified squamous epithelia. Type VII collagen fibrils are composed of three identical alpha collagen chains. Forms anchoring fibrils, which may contribute to epithelial basement membrane organization and adherence by interacting with extracellular matrix (ECM) proteins such as type IV collagen. Dystrophic epidermolysis bullosa can result from defects in this protein or an autoimmune response made to type VII collagen. Homotrimer. Interacts with MIA3, facilitating its loading into transport carriers and subsequent secretion. 2 isoforms of the human protein are produced by alternative splicing. Protein type: Extracellular matrix; Secreted, signal peptide; Secreted; Inhibitor. Chromosomal Location of Human Ortholog: 3p21.1. Cellular Component: basement membrane; collagen type VII; endoplasmic reticulum lumen; ER to Golgi transport vesicle; ER-Golgi intermediate compartment membrane; extracellular matrix; extracellular region; extracellular space; Golgi membrane. Molecular Function: identical protein binding; protein binding; serine-type endopeptidase inhibitor activity. Biological Process: cell adhesion; collagen catabolic process; COPII coating of Golgi vesicle; epidermis development; ER to Golgi vesicle-mediated transport; extracellular matrix organization and biogenesis. Disease: Epidermolysis Bullosa Dystrophica, Autosomal Dominant; Epidermolysis Bullosa Dystrophica, Autosomal Recessive; Epidermolysis Bullosa Dystrophica, Pretibial; Epidermolysis Bullosa Pruriginosa; Epidermolysis Bullosa With Congenital Localized Absence Of Skin And Deformity Of Nails; Nail Disorder, Nonsyndromic Congenital, 8; Transient Bullous Dermolysis Of The Newborn
size1 :
0.1 mg
price1 :
190 USD
more info or order :
company information
MyBioSource
P.O. Box 153308
San Diego, CA 92195-3308
sales@mybiosource.com
https://www.mybiosource.com
1-888-627-0165
headquarters: USA
MyBioSource, LLC was orginally founded in Vancouver by three enthusiastic scientists who are passionate about providing the world with the best reagents available. Together, they form a company with a big vision known as MyBioSource. MyBioSource is now located in San Diego, California, USA.

"MyBioSource's number 1 vision is to be the world's number 1 quality reagents provider."

Our goal is to provide researchers, scientists and customers alike with a one-stop-shop for all of their reagents needs, whether it is monoclonal antibody, polyclonal antibody, recombinant protein, peptide, etc...

"MyBioSource offers the best products at unbeatable prices."

Please spend a few minutes to browse our online catalogs and see the wide range of products available. We ship our products through our shipping/distribution facility in San Diego, California, USA.

Would you like to receive email and e-newsletter from MyBioSource about new products, special offers and events? Please click here to join our Mailing List!